The children's vaccine initiative : achieving the vision
Author(s)
Bibliographic Information
The children's vaccine initiative : achieving the vision
National Academy Press, 1993
Available at 2 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Support provided by the Agency for International Development, the Dept. of Health and Human Services, the Pharmaceutical Manufacturers Association, the United Nations Development Program, and the World Health Organization, Children's Vaccine Initiative
Includes bibliographical references
Description and Table of Contents
Description
The Children's Vaccine Initiative is an international endeavor to ensure that children throughout the world are immunized. This book notes that one of the best opportunities to address the growing problem of immunization in the United States and to improve the health of children in developing countries lies in marshaling the vaccine development and production efforts in the United States and abroad. The book contains information on the nature and status of vaccine development and production efforts in the United States and abroad, and it recommends ways to enhance participation in the International Children's Vaccine Initiative.
Table of Contents
FRONT MATTER
1 Executive Summary
2 Why a Children's Vaccine Initiative
3 Resources and Infrastructure
4 Vaccine Demand and Supply
5 Investing in New and Improved Vaccines
6 Stages of Vaccine Development
7 A Strategy to Enhance U.S. Participation in the Children's
Vaccine Initiative
Appendix A: Relevant Intellectual Property Rights Law
Appendix B: National Vaccine Injury Compensation Program
Appendix C: Regulatory Aspects of Vaccine Development, Manufacture,
and Distribution
Appendix D: Strategies for Achieving Full U.S. Participation in the
Children's Vaccine Initiative
Appendix E: Public Health Service Act (1944)
Appendix F: National Vaccine Program Legislation
Appendix G: Immunization Schedules
Appendix H: Historical Record of Vaccine Product License Holders in
the United States
Appendix I: Working Group Participants
Appendix J: Committee and Staff Biographies
Appendix K: Acronyms
Table of Contents
- 1 FRONT MATTER
- 2 1 Executive Summary
- 3 2 Why a Children's Vaccine Initiative
- 4 3 Resources and Infrastructure
- 5 4 Vaccine Demand and Supply
- 6 5 Investing in New and Improved Vaccines
- 7 6 Stages of Vaccine Development
- 8 7 A Strategy to Enhance U.S. Participation in the Children's Vaccine Initiative
- 9 Appendix A: Relevant Intellectual Property Rights Law
- 10 Appendix B: National Vaccine Injury Compensation Program
- 11 Appendix C: Regulatory Aspects of Vaccine Development, Manufacture, and Distribution
- 12 Appendix D: Strategies for Achieving Full U.S. Participation in the Children's Vaccine Initiative
- 13 Appendix E: Public Health Service Act (1944)
- 14 Appendix F: National Vaccine Program Legislation
- 15 Appendix G: Immunization Schedules
- 16 Appendix H: Historical Record of Vaccine Product License Holders in the United States
- 17 Appendix I: Working Group Participants
- 18 Appendix J: Committee and Staff Biographies
- 19 Appendix K: Acronyms
by "Nielsen BookData"